Performance of BRCA1/2 mutation prediction models in male breast cancer patients

Autor: Moghadasi, S., Grundeken, V., Janssen, L.A.M., Dijkstra, N.H., Rodriguez-Girondo, M., Zelst-Stams, W.A.G. van, Oosterwijk, J.C., Ausems, M.G.E.M., Oldenburg, R.A., Adank, M.A., Blom, E.W., Ruijs, M.W.G., Os, T.A.M. van, Deurzen, C.H.M. van, Martens, J.W.M., Schroder, C.P., Wijnen, J.T., Vreeswijk, M.P.G., Asperen, C.J. van

Publikováno v: Clinical Genetics, 93(1), 52-59. Wiley-Blackwell
Clinical Genetics
Clinical genetics, 93(1), 52-59. Wiley-Blackwell
Clinical Genetics, 93(1), 52-59. Wiley
Clinical Genetics, 93(1), 52-59. Wiley-Blackwell Publishing Ltd
Moghadasi, S, Grundeken, V, Janssen, L A M, Dijkstra, N H, Rodríguez-Girondo, M, van Zelst-Stams, W A G, Oosterwijk, J C, Ausems, M G E M, Oldenburg, R A, Adank, M A, Blom, E W, Ruijs, M W G, van Os, T A M, van Deurzen, C H M, Martens, J W M, Schroder, C P, Wijnen, J T, Vreeswijk, M P G & van Asperen, C J 2018, ' Performance of BRCA1/2 mutation prediction models in male breast cancer patients ', Clinical Genetics, vol. 93, no. 1, pp. 52-59 . https://doi.org/10.1111/cge.13065

To establish whether existing mutation prediction models can identify which male breast cancer (MBC) patients should be offered BRCA1 and BRCA2 diagnostic DNA screening, we compared the performance of BOADICEA (Breast and Ovarian Analysis of Disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5e45b06f49d42d92d16cf4f7cbc8df09
https://research.vumc.nl/en/publications/380b6b64-8984-4d28-ac02-afc2d785d636

P5.3 Fatigue and daytime sleepiness scale in myotonic dystrophy type 1

Autor: Hermans, M.C.E., Merkies, I.S.J., Laberge, L., Blom, E.W., Vanhoutte, E.K., Tennant, A., Faber, C.G.

Publikováno v: In Neuromuscular Disorders October 2011 21(9-10):724-724

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.